XML 89 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONCENTRATIONS
12 Months Ended
Dec. 31, 2013
Risks and Uncertainties [Abstract]  
Concentration Risk Disclosure [Text Block]
18.
CONCENTRATIONS
 
Major Customers
 
For the years ended December 31, 2013, 2012 and 2011, approximately 26%, 13% and 13% of the Company’s revenues were received from two major customers.
 
No customer represented more than 10% of amounts receivable at December 31, 2013 and 2012, respectively. At December 31, 2011, receivables from two customers were approximately 12% and 10%, respectively.
 
Major Suppliers
 
At December 31, 2013, 2012 and 2011, payables due to three suppliers were approximately 43%, 25% and  15% of payables, 34%, 33% and  19% of payables, 50%, 8% and 6% of payables, respectively.
 
Revenues
 
For the years ended December 31, 2013, 2012 and 2011, the Company’s top three selling products accounted, in the aggregate, for approximately 67%, 68% and 27%, respectively, of its total net revenues.
 
The following represents the revenues by product line, all derived from China:
 
 
 
For the years ended
 
 
 
December 31,
 
 
 
2013
 
2012
 
2011
 
 
 
US$
 
US$
 
US$
 
Products Line
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Medical Devices
 
14,824,028
 
18,547,635
 
19,362,673
 
Respiratory and Oxygen Homecare
 
2,034,150
 
2,822,690
 
2,276,610
 
 
 
16,858,178
 
21,370,325
 
21,639,283